Alumni Ventures

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in major cities across North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies with an alumni connection and supported by established institutional lead investors. Alumni Ventures aims to provide accredited investors, particularly alumni from top entrepreneurial schools, with access to diversified venture portfolios that span various sectors and geographic regions. The firm typically invests between $0.01 million and $3 million and does not require board or observer seats in its portfolio companies. Through its managed fund families, Alumni Ventures enables investors to participate in a collaborative investment approach, fostering connections among alumni while facilitating investment opportunities in innovative ventures.

Rob Adams

Managing Partner

Gail Ball

Venture Scout

Andrew Baum

Vice President, Treasury and Capital Management

David Beazley

Executive Partner

Ali Byrd

Investor Advisory Council Member

Matt Caspari

Managing Partner, Strawberry Creek and amp; Deep Tech

Matt Castellini

Senior Associate

Helen Chen

CEO Services Analyst

Cainon Coates

Managing Partner

Michael Collins

CEO

Thomas Edwards

Associate

Yev Gelfand

Investor

Mason Hale

Senior Associate, Chestnut Street and Triphammer Ven

Jin Kim

Senior Vice President, Office of Investments

Lucas Kirshenbaum

VC Investor

Ron Levin

Managing Partner, AV Seed Fund and Doctors Innovate Fund

Jess Liu-Brown

Principal

Michael Madden

Co-Founder and Investment Professionals

Jonathan Meltzer

Managing Partner

Tom Meyer

Managing Partner, Nassau Street

Keith Murphy

Director, Video Programs

David Muson

CFO

Aisha Robinson

Comms Team VP of Strategic Communications

Saad Shaheen

Investor Operations Manager

Stephen Stolzenberg

Senior Associate

Justin Strausbaugh

Managing Partner, Lakeshore

Brittney Wade

Senior Associate, Seed Fund

Sarah Worden

Venture Scout

Wesley Yiu

Partner

Henri Yuan

Investor

Michael Yuann

Director of Investment Operations

Past deals in Wisconsin

Benny

Pre Seed Round in 2022
Benny operates an employee-focused lending platform that allows employees of publicly traded companies to access funds for participating in their employer's stock purchase plans. By providing loans specifically designed for this purpose, Benny enables employees to purchase company stock at discounted prices, enhancing their investment opportunities. This service aims to empower employees to make the most of their earning potential through involvement in stock ownership, thereby fostering a more engaged workforce and promoting long-term financial growth.

Lumanu

Series A in 2021
Lumanu, Inc. is a digital marketing platform that connects companies with brand ambassadors, focusing on the creator economy. Founded in 2016 and headquartered in Oakland, California, with an additional office in Milwaukee, Wisconsin, Lumanu offers several solutions to facilitate collaboration between brands and creators. Its SocialCert solution enables influencers to share content and usage rights with marketers, while Content Manager allows for easy ingestion of influencer content. SmartBoost generates advertisements using influencer-created content, enhancing marketing effectiveness. Lumanu streamlines business transactions and payments for creators, ensuring they earn more and receive payments promptly. For businesses, the platform reduces friction in accessing exclusive creator intellectual property and first-party data, ultimately improving return on investment.

Leo Cancer Care

Series B in 2021
Developer of a cancer treatment system designed to simplify cancer radiation therapy. The company's system is integrated with a radiotherapy machine specializing in 3D image capturing, controlling radiation beams, and automatically delivering the right amount of energy to the right tissue, enabling patients to access and connect with a centralized cancer care center for cancer radiation therapies and reduce the pain and cost of chemo and radiation therapy.

SHINE Technologies

Series C in 2021
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

Full Reign

Seed Round in 2020
Full Reign, founded in 2020 and based in Milwaukee, Wisconsin, operates a recommendation platform focused on hair-care products. The company specializes in formulating sustainable hair care solutions tailored for wavy to curly hair types. By providing alternatives that simplify the hair routine, Full Reign aims to enhance the customer experience while minimizing environmental impact through its innovative packaging and refill processes. This approach not only reduces costs for consumers but also promotes responsible hair care practices.

SHINE Technologies

Venture Round in 2020
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

LÜM

Seed Round in 2020
LÜM is a Madison-based startup that has developed a streaming music platform and social network aimed at supporting emerging artists. The platform enables fans to discover, share, and directly support up-and-coming musicians from around the world. By focusing on local talent, LÜM seeks to bridge the gap in exposure between established artists and new music, fostering a community that promotes undiscovered sounds. The application reimagines the intersection of social media and music streaming, positioning itself as a talent pool for live entertainment. Through its innovative approach, LÜM allows artists to monetize their work and engage with fans throughout their careers, ultimately contributing to a more equitable music landscape.

Asto CT

Venture Round in 2019
Asto CT LLC specializes in developing X-ray computed tomography (CT) systems specifically for equine imaging, aimed at enhancing the care and safety of thoroughbreds, show, recreational, and older horses. Founded in 2015 and based in Madison, Wisconsin, the company offers advanced imaging solutions that improve fracture risk detection, diagnose lameness, and address dental and sinus issues without the need for general anesthesia. Their flagship product, Equina, provides rapid 3D imaging of horses' lower limbs, head, and neck while ensuring a safe and comfortable environment for the animals. By integrating cutting-edge robotics with advanced multi-slice CT technology, Asto CT enhances veterinary diagnostics and treatment, particularly for conditions affecting the distal limb and diseases of the head and neck.

Somna Therapeutics

Venture Round in 2018
Somna Therapeutics LLC is a medical device company based in Germantown, Wisconsin, founded in March 2012 in partnership with the Medical College of Wisconsin. The company specializes in the development of innovative solutions for laryngopharyngeal reflux (LPR) and extraesophageal acid reflux diseases. Its primary product, the Reza Band, is a non-pharmacologic investigational device that aims to prevent reflux into the larynx, pharynx, and lungs. Somna Therapeutics is focused on optimizing its product design and completing clinical trials to achieve FDA clearance. Following this clearance, the company plans to market its devices to hospitals, physician clinics, and home health care providers, ultimately striving to improve the quality of life for individuals affected by these conditions.

SimpleMachines

Series A in 2018
SimpleMachines, Inc. is a semiconductor design and development company based in Madison, Wisconsin, established in 2016. It specializes in creating a Software-Defined Compute platform that addresses the evolving demands of artificial intelligence, virtual reality, machine learning, robotics, and big data. As traditional computing systems face limitations due to the end of Moore's Law and the increasing complexity of software, SimpleMachines offers a programmable platform that allows for real-time hardware optimization. This innovative approach contrasts with conventional single-purpose systems, which are costly, time-consuming to develop, and often become obsolete upon deployment. The company's platform enables software developers to enhance application performance by dynamically reconfiguring hardware, thus supporting a wide range of use cases and ensuring adaptability in rapidly changing technological environments.

HealthMyne

Series B in 2018
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative search, analytics, and imaging solutions primarily for cancer care providers. The company's smart imaging technology supports clinical decision-making by offering real-time, evidence-based insights that enhance diagnostic accuracy and foster collaboration among healthcare professionals. HealthMyne's platform includes features such as automatic tumor staging, dose overlays, specialized reporting, and management of incidental findings, all aimed at improving patient care and optimizing the efficiency of clinical workflows. By integrating electronic health record capabilities with advanced imaging solutions, HealthMyne seeks to reduce care delivery costs while ensuring that clinicians have access to relevant patient information for informed treatment decisions.

SHINE Technologies

Series B in 2018
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

HealthMyne

Venture Round in 2017
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative search, analytics, and imaging solutions primarily for cancer care providers. The company's smart imaging technology supports clinical decision-making by offering real-time, evidence-based insights that enhance diagnostic accuracy and foster collaboration among healthcare professionals. HealthMyne's platform includes features such as automatic tumor staging, dose overlays, specialized reporting, and management of incidental findings, all aimed at improving patient care and optimizing the efficiency of clinical workflows. By integrating electronic health record capabilities with advanced imaging solutions, HealthMyne seeks to reduce care delivery costs while ensuring that clinicians have access to relevant patient information for informed treatment decisions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.